Medscape

Fremanezumab for Pediatric Migraine Prevention: Phase 3 SPACE Trial Results

Results of the SPACE trial demonstrating the safety and efficacy of subcutaneous fremanezumab for the prevention of pediatric ...

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Pl…

AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin ...

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial ...

AJOVY demonstrated efficacy and a consistent safety profile in the SPACE trial, making it the first and only calcitonin gene-related peptide ...
The Pharma Letter

Pivotal Ajovy data published in NEJM

Israeli pharma and generics player Teva (NYSE: TEVA), says the New England Journal of Medicine has published Phase III data ...
Le LézardOpinion

AMERICAN FOUNDATION FOR SUICIDE PREVENTION URGES IMMEDIATE REVERSAL OF SAMHSA GRANT TERMINATIONS THAT SUPPORT LIFE-SAVING CARE IN COMM…

The American Foundation for Suicide Prevention (AFSP), the nation's largest suicide prevention organization, is deeply ...
Le Lézard

no name brand Beef Burgers recalled due to E. coli O157:H7

Food - Microbial contamination - E. Coli O157:H7Distribution: National Online link SOURCE Canadian Food Inspection Agency (CFIA) ...
pharmaphorum

FDA approves Teva's migraine drug, decision due on Lilly's rival

The FDA has finally approved Teva’s potential blockbuster migraine drug Ajovy after months of delays due to concerns about the manufacturing plant operated by the company’s partner, Celltrion. Teva ...